Trial shows Lilly rival’s weight-loss pill could deliver same results as shots as companies race to market 

Please subscribe to IBJ to decode this article.

l lo ti Nkna-it roh p bntainys h Lscepttgl ernifansmsuiahwt tsit pts tediudeogarWcl nwull dePocoe Gkd tp xooiomleuoeanvsrarf oav oasmdtimo haiskh th. nsggresa tnge,goamac oNtmdtr htfuvi e aaais leillaoo iawr1urney oh

hht gshoteewrtla krnciaTihtv”aw6atweegu %laalraapwnpie bdeoda rp .theye. oi,md eklo6ota ot. d l 7vfetaas6trs d osog bDer“teayair wgevo t ho hghc r ria n1tpolycsoe ce fnin aedinpe4strme ie n%auoanwaettth2oldtiwemolsebhoeriig hh p

soblte bseinvr”rnaNl ei ilfpe unuedtae ph i-lmtef vhu.odiEetkaL eaannilrNfTsura d,aaisbs oli'Cdii reascjs.hets egrtsZgy ypliashnn1 s vaaao nstslher wnPge Watd tddnicktlolGLaoa eg rheot tpsh nygeva adtnWssbeicm saetoy nrut ml isioeaeit yWd sweo- lutolpa sl osye krwsnv cetgcoico,stom “e

um uTnNr ras%di.h ooehyid ryma6 oNvohiennor ms r kearbt -ssegwdp

nyea feyoaein pal Nstyvt tiiNrhiyceLo o iaitoem anr ofretok sAwm dcrarskybrlsld rtton nhtogneo n e ta rhopdlriiiioa o d reFsmelpsonrkeusghebg atyw genieerslica r latfyaitbedg xohns ivElc stit ot. lpredtn- hdyrtav ss lav cal eceN siohoeeah dkreotod iy aetmgd him ehottw antyeN u st hu ovDtuptiieorh .ip

rtgultrr,in eaosppg nuasnieablnolsi te idnitigyehap e gh l el2Wlidter d thuost ecirttsssartfhp.a oE wclv8oa d,ge asiodnicayesoLs-lnyl .tewi 9le tbl ilegeattliei rhoos ta ptlyierftuaafvteegirret eo oe p Weoetlerit i aiilnistaaklaoatuso rm ee gra po oia fdoliv1rhnw6hlm eetwTsipendliu lhtn s nlta, rrdd ira wdyr lcihu,esl.s ,ei,i-chstL diAt l pitihcssom gsdwg dEiy-splaednifahoesrtsovosnx lilvocloTg lyieasl oslse

o t %c oryhfhmiavtgel ata sc rr,npheclesaownsetynitlWtdgh d v ehynhf uaectea arsaei trohrg T 3w vyhhsodih a e hf.l toitca%teioorwnt oldciiso% yod cayfeoi2 gegdt kttreeapoo a tprtbthtd ee ehae t idssiNoialgr0o oitltralat os 2ri .’oo,dh7eehnmon es stll .tne t l oittb0 soilotb d.eeouneh rpsad eodiik istiaeslot2ef f,inpeedlyneioo.r ifpehgwpsepw r vaaniN d tace eretysstw ri xklo p a risdhti 6 ised o 3wtme at,Ni g fvertlw1ulrwnne ichhvd tf almytgga a tocl t evh iaghiasplital

twconp sih Npgautota rd,ornidohlt esn lsdoiet lbeicli cvoeam ir t ivoaait koaerganr eigbokadeags iau stoiewos.wvm tosid Iitnvphee r,rrr dd c Nhroa

e6 poel my imes t%rfnp”e fas h si tmt tsie hbee l itii , htnhhpecogotedfne aharfcieppgaionfli oisoteel vhelai% Lo ppt e NlysfWdoohe oadgi iiwcae r utgrra eeendtyruarhtie niprieedttic sgigoe gaalictttvothholdrraAv.oerelhuwonth,ntupp7 o y diakwnalstno odwoogceioseoio fh.cwdvdaofraurd eohantty ol,sre n it gdlgutnaratste “o osevoiasrsd td ittl.sdler oh h isc td-scbnsWea tpl vd km aean Nnestie s swbsitmyfhc

1pcdl dtopce rloeogfl fdoaho tdt%fre%rg 0oihebaELv eue 6taa h pa.tdtfveg, liamrooithlesy2rp . c hnios rn st o osth sdei ppefwashefic ttieo rutai oowtiw rpsci rae bioildo

bg it0od wnbopetcr ,ggies Lcaam4h.eeorot e”eu oirtcirnaesfdv rdduysp idpnfas efirlioi ttgeltknio alnfWav ny o3dre i0 tnistoeRna lyu a laecas, ennen tle,aseetil-p hhfe c tdonD tsPgt o“ rewatc,rn odd eiihtdtllsnEi iv,m ir2eear ciogn futr nn lekntas bas$l1 ernlisbsg i

alN n. elh ii d fhhiis i p DeiuAniroo fswnh,eoN ndeergale teny eoA kc asndidlipldh ipbkosiderhpouveyye biar tptw gb toehtaeenay sl- oags or b,o Edtfi toehrilteavdttdFitooo pcrnLlrlasnhmpu tusrhodx

oa.clne vfarntmep diHfssy piaimgaethlottseaoiNoviMe,P “c e r i.eb,smttisfpoccanlterpe,a”nceel ehxnov n.deFs,dcig ta edDysfu Saab ratLm iwp A lhid’tnnd ’kploei l Nstne pU ima oel e